Skip header and navigation

10 records – page 1 of 1.

Azathioprine for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38301
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2421
Available Online
View Pamphlet
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Azathioprine
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2421
Less detail

Azathioprine or mercaptopurine therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1079
Available Online
View Pamphlet
Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Azathioprine or mercaptopurine therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Previous title: Azathioprine and mercaptopurine therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail

Cyclophosphamide for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38303
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2422
Available Online
View Pamphlet
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Cyclophosphamide
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2422
Less detail

Cyclosporine for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38298
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2418
Available Online
View Pamphlet
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Cyclosporine
Glomerulonephritis
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2418
Less detail

Cytomegalovirus (CMV)

https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1999
Available Online
View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Cytomegalovirus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Cytomegalovirus infections
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1999
Less detail

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1138
Available Online
View Pamphlet
Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Methotrexate (MTX) therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Medications
Abstract
Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Mycophenolate for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38300
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2420
Available Online
View Pamphlet
Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Mycophenolic Acid
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2420
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Rituximab for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38304
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2423
Available Online
View Pamphlet
Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Rituximab
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2423
Less detail

Tacrolimus for glomerulonephritis

https://libcat.nshealth.ca/en/permalink/chpams38305
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
2424
Available Online
View Pamphlet
Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Tacrolimus
Glomerulonephritis
Immunosuppressive Agents
Subjects (LCSH)
Immunosuppressive agents
Kidneys--Diseases--Treatment
Abstract
Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2424
Less detail

10 records – page 1 of 1.